0-2 days following admission | 3-7 days following admission** | 8-30 days following admission† | 31-180 days following admission‡ | ||||||
---|---|---|---|---|---|---|---|---|---|
Comorbidity | Blood culture status | Mortality, % (95% CI) | Adjusted MRR* (95% CI) | Mortality, % (95% CI) | Adjusted MRR (95% CI) | Mortality, % (95% CI) | Adjusted MRR (95% CI) | Mortality, % (95% CI) | Adjusted MRR (95% CI) |
Low | Negative | 1.4 (1.2-1.6) | 1.0 (ref) | 1.9 (1.6-2.1) | 1.0 (ref) | 3.4 (3.1-3.7) | 1.0 (ref) | 5.0 (4.6-5.4) | 1.0 (ref) |
Positive | 3.7 (2.8-5.0) | 1.8 (1.4-2.5) | 2.4 (1.6-3.4) | 0.9 (0.6-1.4) | 4.0 (3.0-5.3) | 0.9 (0.7-1.2) | 6.8 (5.4-8.4) | 1.1 (0.8-1.4) | |
Medium | Negative | 2.3 (2.0-2.6) | 1.0 (ref) | 3.1 (2.8-3.5) | 1.0 (ref) | 6.1 (5.6-6.6) | 1.0 (ref) | 10.7 (10.0-11.3) | 1.0 (ref) |
Positive | 5.3 (4.1-6.9) | 1.9 (1.4-2.4) | 4.3 (3.1-5.8) | 1.4 (1.0-1.9) | 5.9 (4.5-7.6) | 0.9 (0.7-1.2) | 10.9 (9.0-13.2) | 0.9 (0.7-1.2) | |
High | Negative | 3.4 (2.9-4.1) | 1.0 (ref) | 4.5 (3.9-5.3) | 1.0 (ref) | 9.2 (8.3-10.2) | 1.0 (ref) | 18.1 (16.8-19.5) | 1.0 (ref) |
Positive | 6.8 (4.8-9.7) | 2.0 (1.5-2.9) | 6.6 (4.5-9.5) | 1.1 (0.7-1.9) | 10.0 (7.4-13.6) | 1.0 (0.7-1.5) | 16.9 (13.3-21.4) | 0.9 (0.7-1.2) |